GE HealthCare Tops Q4 EPS, Revenue Estimates and Delivers 7.5% Surprise
GE HealthCare reported Q4 2025 adjusted EPS of $1.44 and revenues of $5.7 billion, topping consensus by 0.7% and 1.9%. The company holds a Zacks Rank #2 Buy rating, has a 9.1% projected long-term earnings growth rate versus the industry’s 12.9%, and averaged 7.5% EPS surprises.
1. Q4 2025 Earnings Outperform Estimates
GE HealthCare posted adjusted EPS of $1.44 for Q4 2025, beating the consensus by 0.7%, and reported revenues of $5.7 billion, exceeding estimates by 1.9%, reflecting solid end-of-year demand across imaging and ultrasound segments.
2. Zacks Rank #2 and Growth Projections
The company holds a Zacks Rank #2 (Buy) rating and projects long-term earnings growth of 9.1% compared with the industry’s 12.9%, indicating moderate expansion driven by service contracts and software enhancements.
3. Consistent Forecast Beats
GE HealthCare has exceeded earnings estimates in each of the past four quarters, with an average EPS surprise of 7.5%, highlighting improving forecast accuracy and operational execution across its healthcare technology businesses.